Ron Christopher Charles - Oct 1, 2023 Form 3 Insider Report for Chemours Co (CC)

Role
Senior Vice President, People
Signature
/s/ Nicole Perez Lengel, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Oct 1, 2023
Transactions value $
$0
Form type
3
Date filed
10/3/2023, 07:53 PM
Next filing
Nov 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CC Common Stock 17.5K Oct 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CC Stock Option (Right to Buy) Oct 1, 2023 Common Stock 5.05K $34.84 Direct F2
holding CC Stock Option (Right to Buy) Oct 1, 2023 Common Stock 6.07K $25.98 Direct F3
holding CC Stock Option (Right to Buy) Oct 1, 2023 Common Stock 6.65K $24.01 Direct F4
holding CC Stock Option (Right to Buy) Oct 1, 2023 Common Stock 2.8K $48.53 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes stock units and dividend equivalent units.
F2 Option award was granted on March 1, 2023 with vesting in three equal annual installments beginning March 1, 2024.
F3 Option award was granted on March 1, 2022 with vesting in three equal annual installments beginning March 1, 2023.
F4 Option award was granted on March 1, 2021 with vesting in three equal annual installments beginning March 1, 2022.
F5 Options are fully vested.

Remarks:

Power of Attorney attached as Exhibit 24.